News

MedGene Therapeutics Publishes Preclinical Data Demonstrating RIV-8’s Ability to Overcome T Cell Exhaustion in the Journal Science Advances.

MedGene Therapeutics' CMO Moon Yong-hwa, professor from the Department of Hematology and Oncology at CHA Bundang Hospital, won the Best Oral Presentation Award from the Korean Society of Medical Oncology..."Proving the effectiveness of next-generation immune cell therapy"

CMO Yong Wha Moon presents preclinical findings on PBL-T to the Korean Society of Medical Oncology Annual meeting in Seoul.

MedGene Therapeutics presents preclinical findings at Society for Immunotherapy of Cancer in Washington, DC.